Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects

被引:0
|
作者
Lin, Jingyi [1 ,3 ]
Zhao, Yujie [1 ]
Chen, X. Gregory [2 ]
Donica, Margarita [2 ]
Leon, Larry
Trinquart, Ludovic [3 ,4 ,5 ]
Wan, Shuyan Sabrina [1 ]
机构
[1] Merck & Co Inc, Biostat & Res Decis Sci, Rahway, NJ 07065 USA
[2] MSD Innovat & Dev GmbH, Biostat & Res Decis Sci, Zurich, Switzerland
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA USA
[5] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
关键词
Informative censoring; Randomized clinical trial; Coupla; Nonproportional hazard ratio; Survival analysis; PROGRESSION-FREE SURVIVAL; INVERSE-PROBABILITY; RANK; NONCOMPLIANCE; SENSITIVITY; ASSUMPTION; TIME;
D O I
10.1016/j.cct.2025.107860
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Time-to-event endpoints like progression-free survival in oncology randomized trials sometimes demonstrate differential censoring patterns between study arms which can be indicative of informative censoring, depending on censoring reasons. Informative censoring can bias treatment effect estimates but few simulation studies characterized the magnitude of its impact, particularly in the context of therapies with delayed treatment effects. We used copula methods to model dependent censoring data and assessed the impact of informative censoring. To improve the understanding of copula models in this context, we proposed a new measure of the strength of informative censoring, the probability of events being informatively censored. We further proposed a visual tool for examining the underlying correlation pattern between censoring and event time. We conducted simulation studies to assess the impact of informative censoring on estimation bias for hazard ratios, as well as on empirical power of unweighted, weighted log-rank tests, and the MaxCombo test. We implemented data generation algorithm for copula survival models with piece-wise exponential marginals to introduce various censoring patterns under scenarios with delayed treatment effect. We found large overestimation of hazard ratio of the experimental arm versus the control arm and loss in power when there was a positive correlation between event time and censoring time in the control arm and a negative correlation in the experimental arm. When correlations in both arms were of the same direction and degree, we observed minimal impact on hazard ratio estimate and statistical powers.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Efficient nonparametric estimation of causal effects in randomized trials with noncompliance
    Cheng, Jing
    Small, Dylan S.
    Tan, Zhiqiang
    Ten Have, Thomas R.
    BIOMETRIKA, 2009, 96 (01) : 19 - 36
  • [22] Estimation of treatment effects in early-phase randomized clinical trials involving external control data
    Goette, Heiko
    Kirchner, Marietta
    Krisam, Johannes
    Allignol, Arthur
    Schueler, Armin
    Kieser, Meinhard
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (05) : 680 - 699
  • [23] Interval Estimation of Treatment Effects in Randomized Trials: When do Confidence Intervals Have Nominal Coverage?
    Scosyrev, Emil
    INTERNATIONAL STATISTICAL REVIEW, 2012, 80 (03) : 439 - 451
  • [24] Reader reaction on estimation of treatment effects in all-comers randomized clinical trials with a predictive marker
    Korn, Edward L.
    Freidlin, Boris
    BIOMETRICS, 2017, 73 (02) : 706 - 708
  • [25] New approaches for estimation of effect sizes and their confidence intervals for treatment effects from randomized controlled trials
    Feingold, Alan
    QUANTITATIVE METHODS FOR PSYCHOLOGY, 2019, 15 (02): : 96 - 111
  • [26] Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study
    Pedroza, Claudia
    Han, Weilu
    Van Thi Thanh Truong
    Green, Charles
    Tyson, Jon E.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (01) : 79 - 96
  • [27] Individual treatment effects in randomized trials with binary outcomes
    Gadbury, GL
    Iyer, HK
    Albert, JM
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2004, 121 (02) : 163 - 174
  • [28] Mediators and moderators of treatment effects in randomized clinical trials
    Kraemer, HC
    Wilson, GT
    Fairburn, CG
    Agras, WS
    ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (10) : 877 - 883
  • [29] Testing Treatment Effect in Randomized Clinical Trials With Possible Nonproportional Hazards
    Callegaro, Andrea
    Spiessens, Bart
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (02): : 204 - 211
  • [30] IMPACT OF RANDOMIZED CONTROL TRIALS (RCTS) ON THE TREATMENT OF ALCOHOL WITHDRAWAL
    MOSKOWITZ, G
    SACKS, H
    CHALMERS, TC
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1982, 6 (01) : 149 - 149